Safety and efficacy of 177lu-PSMA-617 radioligand therapy in patients with mCRPC: A multicenter study.

被引：2
|
作者：
Rahbar, Kambiz
Ahmadzadehfar, Hojjat
Kratochwil, Clemens
Baum, Richard P.
Schmidt, Matthias
Pfestroff, Andreas
Prasad, Vikas
Heinzel, Aelxander
Ruf, Juri
Eveslage, Maria
Boegemann, Martin
Fendler, Wolfgang
Krause, Bernd J.
机构：
[1] Univ Hosp Muenster, Dept Nucl Med, Munster, Germany
[2] Univ Hosp Bonn, Dept Nucl Med, Bonn, Germany
[3] Heidelberg Univ, Dept Nucl Med, Heidelberg, Germany
[4] Zentralklin Bad Berka, Bad Berka, Germany
[5] Univ Cologne, Dept Nucl Med, Cologne, Germany
[6] Univ Marburg, Dept Nucl Med, Marburg, Germany
[7] Charite, Dept Nucl Med, Med Ctr, Berlin, Germany
[8] Univ Aachen, Dept Nucl Med, Aachen, Germany
[9] Univ Freiburg, Dept Nucl Med, Freiburg, Germany
[10] Univ Hosp Muenster, IBKF, Munster, Germany
[11] Univ Munster, Med Ctr, Munster, Germany
[12] Univ Munich LMU, Dept Nucl Med, Munich, Germany
[13] Univ Rostock, Dept Nucl Med, Rostock, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 06期
关键词：
D O I：
10.1200/JCO.2017.35.6_suppl.155
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
155
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of [225Ac]Ac-PSMA-617 Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor Prognosis
    Rosar, Florian
    Krause, Jonas
    Bartholoma, Mark
    Maus, Stephan
    Stemler, Tobias
    Hierlmeier, Ina
    Linxweiler, Johannes
    Ezziddin, Samer
    Khreish, Fadi
    PHARMACEUTICS, 2021, 13 (05)
  • [22] 225Ac-PSMA-617 Augmentation After Insufficient Response Under 177Lu-PSMA-617 Radioligand Therapy in mCRPC: Evaluation of Outcome and Safety From a Prospective Registry (REALITY Study)
    Rosar, Florian
    Khreish, Fadi
    Nagel, Lea Sophie
    Blickle, Arne
    Burgard, Caroline
    Petto, Sven
    Bastian, Moritz B.
    Speicher, Tilman
    Bartholomae, Mark
    Maus, Stephan
    Schaefer-Schuler, Andrea
    Ezziddin, Samer
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (04) : e202 - e206
  • [23] Therapeutic response and safety of radioligand therapy with 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer patients
    Ashfaq, Wardah
    Rehman, Khurram
    Shahid, Abubaker
    Younis, Muhammad Numair
    MEDICAL ONCOLOGY, 2024, 41 (09)
  • [24] 177Lu-PSMA-617 radioligand therapy for a patient with lymph node metastatic prostate cancer
    von Eyben, Finn E.
    Kiljunen, Timo
    Joensuu, Timo
    Kairemo, Kalevi
    Uprimny, Christian
    Virgolini, Irene
    ONCOTARGET, 2017, 8 (39) : 66112 - 66116
  • [25] Management of Dry Eye Toxicity After Treatment With 177Lu-PSMA-617 Radioligand Therapy
    Pepin, Abigail
    Lee, Vivian
    O'Brien, Sophia
    Mulugeta, Philipose
    Taunk, Neil K.
    PRACTICAL RADIATION ONCOLOGY, 2024, 14 (04) : 301 - 304
  • [26] 177Lu-PSMA-617 Radioligand Therapy in Patient With Prostate Cancer Sciatic Nerve Metastasis
    Tonnelet, David
    Edet-Sanson, Agathe
    Augusto, Laetitia
    Cabourg, Marine
    Thureau, Sebastien
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (12) : E668 - E669
  • [27] Establishing 177Lu-PSMA-617 Radioligand Therapy in a Syngeneic Model of Murine Prostate Cancer
    Fendler, Wolfgang P.
    Stuparu, Andreea D.
    Evans-Axelsson, Susan
    Luckerath, Katharina
    Wei, Liu
    Kim, Woosuk
    Poddar, Soumya
    Said, Jonathan
    Radu, Caius G.
    Eiber, Matthias
    Czernin, Johannes
    Slavik, Roger
    Herrmann, Ken
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (11) : 1786 - 1792
  • [28] Radioligand Therapy with 7.4 GBq 177-Lu-PSMA-617 in patients with mCRPC in a 6 weekly interval
    Braeuer, A.
    Seifert, R.
    Gonzalez, J.
    Schrader, A.
    Schaefers, M.
    Boegemann, M.
    Rahbar, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S125 - S126
  • [29] Effect of 177Lu-PSMA-617 radioligand therapy on quality of life in patients with advanced metastatic prostate cancer
    Scheer, C.
    Juptner, M.
    Zhao, Y.
    Zuhayra, M.
    Lutzen, U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S130 - S130
  • [30] 177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer
    Braeuer, Axel
    Grubert, Lena Sophie
    Roll, Wolfgang
    Schrader, Andres Jan
    Schaefers, Michael
    Boegemann, Martin
    Rahbar, Kambiz
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (10) : 1663 - 1670
12345